|drug2790||Remote Ischemic Conditioning Wiki||1.00|
|drug1350||Glucose tablets Wiki||1.00|
|drug1486||Hydroxychloroquine 200 Mg Oral Tablet Wiki||0.71|
|D055370||Lung Injury NIH||0.18|
|D012127||Respiratory Distress Syndrome, Newborn NIH||0.08|
|D055371||Acute Lung Injury NIH||0.08|
There is one clinical trial.
To find the effectiveness of hydroxychloroquine alone and adjuvant with azithromycin in mild to severe Covide-19 pneumonia patients admitted to Coronavirus cell/ward of Ayub Teaching hospital, Abbottabad Pakistan. A single centered, single-blind randomized control trial study.
Description: National Early Warning Score equal to zero is when patients recovered clinically. Respiration 14-20breaths/minute, oxygen saturation percent greater than 96, (without breathing aid), systolic blood pressure 111-180 mmhg, pulse 60-90 beats.minute, alert consciousness and 35.1-38 degree Celsius body temperature.Measure: National Early Warning Score equal to zero Time: 3-5 Days
Description: below 3.0 miligram/Liter of blood sampleMeasure: C-reactive proteins Time: 3-5 Days
Description: 1000 -4800 lymphocytes in 1 microliter of bloodMeasure: Lymphocyte Count Time: 3-5days
Description: less than 250 ng/mL, or less than 0.4 mcg/mL of blood sampleMeasure: d-dimers Time: 3-5days
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports